Radmila Žeravica
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Radmila Žeravica has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Branislava Ilinčić
Department of Pathophysiology and Laboratory Medicine, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia
2 shared publications - Marija Vukmirović Papuga
Center of Laboratory Diagnostic, University Clinical Center of Vojvodina, 21000 Novi Sad, Serbia
2 shared publications - Tanja Šašić-Ostojić
Center of Laboratory Diagnostics University Clinical Centre of Vojvodina 1-9 Hajduk Veljkova Street Novi Sad Serbia
2 shared publications - Ana Jakovljević
Department of Pathophysiology and Laboratory Medicine, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia
1 shared publication Branislava Ilincic
Clinical Center of Vojvodina, Center for Laboratory Medicine, Novi Sad + University of Novi Sad, Faculty of Medicine, Department for Patophysiology and Laboratory Medicine, Novi Sad
1 shared publication- Dalibor Ilić
Center for Radiology, University Clinical Center of Vojvodina, 21000 Novi Sad, Serbia
1 shared publication
Latest Publications
- Open Access
- 17 October 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (20) , 11159
Relationship Between Serum Uromodulin as a Marker of Kidney Damage and Metabolic Status in Patients with Chronic Kidney Disease of Non-Diabetic Etiology
Chronic kidney disease (CKD) is often associated with dyslipidemia, marked by lipid abnormalities that can worsen kidney function and increase cardiovascular risk. A promising biomarker for evaluating kidney function and metabolic status in chronic kidney disease (CKD) is serum uromodulin (sUmod). This study sought to further investigate the relationship between sUmod levels and metabolic status in non-diabetic CKD patients. A sensitive ELISA method was used to determine sUmod levels in 90 adults with obstructive nephropathy and 30 healthy controls. Kidney function was assessed using the measured glomerular filtration rate (mGFR) through renal clearance of 99mTc-diethylenetriamine penta-acetic acid, along with cystatin C levels. Additionally, glycemic and lipid statuses were evaluated. sUmod concentrations showed a significant association with High-density lipoprotein (HDL) levels. Furthermore, CKD patients with lower sUmod levels had significantly lower Apolipoprotein A-I (Apo A-I) values compared to the control group. Significant predictors of lower sUmod concentrations identified in this study were higher glycemia (B = −15.939; p = 0.003) and lower HDL cholesterol levels (B = 20.588; p = 0.019). We conclude that, in addition to being significantly reduced in CKD patients, sUmod is a potential predictor of metabolic syndrome (MS) in this population. Lower sUmod concentrations, independent of mGFR, predict lower HDL cholesterol levels and higher glycemia values.
- 17 October 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (20) , 11159
Open AccessRelationship Between Serum Uromodulin as a Marker of Kidney Damage and Metabolic Status in Patients with Chronic Kidney Disease of Non-Diabetic Etiology
Chronic kidney disease (CKD) is often associated with dyslipidemia, marked by lipid abnormalities that can worsen kidney function and increase cardiovascular risk. A promising biomarker for evaluating kidney function and metabolic status in chronic kidney disease (CKD) is serum uromodulin (sUmod). This study sought to further investigate the relationship between sUmod levels and metabolic status in non-diabetic CKD patients. A sensitive ELISA method was used to determine sUmod levels in 90 adults with obstructive nephropathy and 30 healthy controls. Kidney function was assessed using the measured glomerular filtration rate (mGFR) through renal clearance of 99mTc-diethylenetriamine penta-acetic acid, along with cystatin C levels. Additionally, glycemic and lipid statuses were evaluated. sUmod concentrations showed a significant association with High-density lipoprotein (HDL) levels. Furthermore, CKD patients with lower sUmod levels had significantly lower Apolipoprotein A-I (Apo A-I) values compared to the control group. Significant predictors of lower sUmod concentrations identified in this study were higher glycemia (B = −15.939; p = 0.003) and lower HDL cholesterol levels (B = 20.588; p = 0.019). We conclude that, in addition to being significantly reduced in CKD patients, sUmod is a potential predictor of metabolic syndrome (MS) in this population. Lower sUmod concentrations, independent of mGFR, predict lower HDL cholesterol levels and higher glycemia values.
- Open Access
Serum Uromodulin, a Potential Biomarker of Tubulointerstitial Damage, Correlates Well with Measured GFR and ERPF in Patients with Obstructive Nephropathy
Background and Objectives: In chronic kidney obstruction, the severity of tubulointerstitial damage correlates best with the loss of kidney function and the risk for progression to end-stage kidney disease. The present study aimed to investigate the potential clinical significance of serum uromodulin (sUmod) as a marker of early kidney disfunction in patient with obstructive nephropathy (ON). Materials and Methods: Serum Umod level was measured by sensitive ELISA method in 57 adult patients with obstructive nephropathy and 25 healthy subjects in control group. Kidney function was precisely evaluated via measured glomerular filtration rate (mGFR) (renal clearance of 99 mTc-diethylenetriamine penta-acetic acid), effective renal plasma flow (ERPF) and Cystatin C level. Recruited patients were divided into subgroups based on the mGFR: group I—GFR ≤ 60 mL/min/1.73 m2 (N = 31), group II—GFR > 60 mL/min/1.73 m2 (N = 26). Results: A significantly lower level of serum uromodulin was measured in patients with ON (50.2 ± 26.3 ng/mL) compared to the control group (78.3 ± 24.5 ng/mL) (p < 0.001). The mean level of serum Umod was significantly different between group I (30.5 ng/mL ± 11.1) and group II (73.6 ng/mL ± 18.6) (p < 0.001), but not between group II (73.6 ng/mL ± 18.6) and control group (78.3 ± 24.5 ng/mL). There was a positive correlation between sUmod and mGFR (R = 0.757, p < 0.001) and ERPF (R = 0.572 p < 0.001), with lower sUmod levels in patients with impaired renal function. An inverse relationship was detected between sUmod and filtration markers—cystatin C (R = −0.625, p < 0.001), creatinine, urea and uric acid. ROC analysis of sUmod to differentiate between ON patients with GFR below 60 mL/min/1.73 m2 and above 60 mL/min/1.73 m2 resulted in AUC of 0.98 (p < 0.001, 95% CI 0.922 vs. 0.998) at a cut-off value of 46 ng/mL (specificity 96.8%, sensitivity 92.2%). Conclusions: The significant correlation of sUmod with kidney function parameters may imply potential clinical significance as a noninvasive biomarker of early kidney disfunction in obstructive nephropathy.
Open AccessSerum Uromodulin, a Potential Biomarker of Tubulointerstitial Damage, Correlates Well with Measured GFR and ERPF in Patients with Obstructive Nephropathy
Background and Objectives: In chronic kidney obstruction, the severity of tubulointerstitial damage correlates best with the loss of kidney function and the risk for progression to end-stage kidney disease. The present study aimed to investigate the potential clinical significance of serum uromodulin (sUmod) as a marker of early kidney disfunction in patient with obstructive nephropathy (ON). Materials and Methods: Serum Umod level was measured by sensitive ELISA method in 57 adult patients with obstructive nephropathy and 25 healthy subjects in control group. Kidney function was precisely evaluated via measured glomerular filtration rate (mGFR) (renal clearance of 99 mTc-diethylenetriamine penta-acetic acid), effective renal plasma flow (ERPF) and Cystatin C level. Recruited patients were divided into subgroups based on the mGFR: group I—GFR ≤ 60 mL/min/1.73 m2 (N = 31), group II—GFR > 60 mL/min/1.73 m2 (N = 26). Results: A significantly lower level of serum uromodulin was measured in patients with ON (50.2 ± 26.3 ng/mL) compared to the control group (78.3 ± 24.5 ng/mL) (p < 0.001). The mean level of serum Umod was significantly different between group I (30.5 ng/mL ± 11.1) and group II (73.6 ng/mL ± 18.6) (p < 0.001), but not between group II (73.6 ng/mL ± 18.6) and control group (78.3 ± 24.5 ng/mL). There was a positive correlation between sUmod and mGFR (R = 0.757, p < 0.001) and ERPF (R = 0.572 p < 0.001), with lower sUmod levels in patients with impaired renal function. An inverse relationship was detected between sUmod and filtration markers—cystatin C (R = −0.625, p < 0.001), creatinine, urea and uric acid. ROC analysis of sUmod to differentiate between ON patients with GFR below 60 mL/min/1.73 m2 and above 60 mL/min/1.73 m2 resulted in AUC of 0.98 (p < 0.001, 95% CI 0.922 vs. 0.998) at a cut-off value of 46 ng/mL (specificity 96.8%, sensitivity 92.2%). Conclusions: The significant correlation of sUmod with kidney function parameters may imply potential clinical significance as a noninvasive biomarker of early kidney disfunction in obstructive nephropathy.
- 1 January 2020
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 73 (5-6) , 139-144
Image-derived index - as a paramether for the semi-quantitative assessment of global tubular renal function
Introduction. Radionuclide methods are used in the evaluation of different aspects of renal function. The aim of this study was to define and implement an index derived from scintigraphic image and to compare it with ortho-iodohippurate clearance values, an indicator of effective renal plasma flow. Material and Methods. A retrospective analysis included 67 adult patients, who underwent static renal scintigraphy and ortho-iodohippurate clearance. We computed the background-to-renal index that represents the ratio of average values of counts per pixel in the background regions and in the regions of kidneys. Patients were divided into three groups according to the values of measured effective renal plasma flow: group 1 - patients with mild renal dysfunction (reduction of effective renal plasma flow ? 20%, 17 patients), group 2 - moderate dysfunction (reduction of effective renal plasma flow 20-50%, 25), and group 3 - severe dysfunction (reduction of effective renal plasma flow 50-70%, 25 patients). Results. Subjects with mild effective renal plasma flow reduction had significantly lower background-to-renal index values compared to those with moderate and severe reduction [(0.105 ? 0.05) vs. (0.134 ? 0.056) vs. (0.275 ? 0.154), p < 0,001]. A significant linear correlation was found between background-to-renal index and effective renal plasma flow (r = 0.60, p < 0.0001). Sensitivity and specificity of the calculated cut-off value of 0.1335, for the differentiation between the patients with renal reduction higher and lower than 20%, were 62% and 100%, respectively (area under curve 0.85). Conclusion. The background-to-renal index is a simple method for semiquantitative estimation of global tubular renal function that can be a useful tool when determining patients for further in vitro assessment of global renal function.
- 1 January 2020
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 73 (5-6) , 139-144
Image-derived index - as a paramether for the semi-quantitative assessment of global tubular renal function
Introduction. Radionuclide methods are used in the evaluation of different aspects of renal function. The aim of this study was to define and implement an index derived from scintigraphic image and to compare it with ortho-iodohippurate clearance values, an indicator of effective renal plasma flow. Material and Methods. A retrospective analysis included 67 adult patients, who underwent static renal scintigraphy and ortho-iodohippurate clearance. We computed the background-to-renal index that represents the ratio of average values of counts per pixel in the background regions and in the regions of kidneys. Patients were divided into three groups according to the values of measured effective renal plasma flow: group 1 - patients with mild renal dysfunction (reduction of effective renal plasma flow ? 20%, 17 patients), group 2 - moderate dysfunction (reduction of effective renal plasma flow 20-50%, 25), and group 3 - severe dysfunction (reduction of effective renal plasma flow 50-70%, 25 patients). Results. Subjects with mild effective renal plasma flow reduction had significantly lower background-to-renal index values compared to those with moderate and severe reduction [(0.105 ? 0.05) vs. (0.134 ? 0.056) vs. (0.275 ? 0.154), p < 0,001]. A significant linear correlation was found between background-to-renal index and effective renal plasma flow (r = 0.60, p < 0.0001). Sensitivity and specificity of the calculated cut-off value of 0.1335, for the differentiation between the patients with renal reduction higher and lower than 20%, were 62% and 100%, respectively (area under curve 0.85). Conclusion. The background-to-renal index is a simple method for semiquantitative estimation of global tubular renal function that can be a useful tool when determining patients for further in vitro assessment of global renal function.